Disruption of the homeostatic balance between autoaggressive (CD4 +CD40+) and regulatory (CD4+CD25 +FoxP3+) T cells promotes diabetes

Journal of Leukocyte Biology

Volumn 84, Issue 2, 2008, Pages 431-439

  Waid, Dan M ^a   Vaitaitis, Gisela M ^a   Pennock, Nathan D ^a   Wagner Jr , David H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Diabetes; Homeostasis; Tolerance; Treg

Indexed keywords

CD40 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOAGGRESSIVE T CELL; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ CD40+ T CELL; CD4+ T LYMPHOCYTE; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; DIABETES MELLITUS; FLOW CYTOMETRY; HOMEOSTASIS; INSULITIS; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD40; CELL DEATH; CELL DIVISION; DIABETES MELLITUS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HOMEOSTASIS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 48649106615     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1207857     Document Type: Article

References (57)

1. Szanya, V., Ermann, J., Taylor, C., Holness, C., Fathman, C. G. (2002) The subpopulation of CD4(+)CD25(+) splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169, 2461-2465.
2. Kent, S. C., Chen, Y., Bregoli, L., Clemmings, S. M., Kenyon, N. S., Ricordi, C., Hering, B. J., Hafler, D. A. (2005) Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435, 224-228.
3. Oling, V., Marttila, J., Ilonen, J., Kwok, W. W., Nepom, G., Knip, M., Simell, O., Reijonen, H. (2005) GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J. Autoimmun. 25, 235-243.
4. Reijonen, H., Novak, E. J., Kochik, S., Heninger, A., Liu, A. W., Kwok, W. W., Nepom, G. T. (2002) Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51, 1375-1382.
5. Gottlieb, P. A., Eisenbarth, G. S. (2002) Insulin-specific tolerance in diabetes. Clin. Immunol. 102, 2-11.
6. Barker, J. M., Barriga, K. J., Yu, L., Miao, D., Erlich, H. A., Norris, J. M., Eisenbarth, G. S., Rewers, M. (2004) Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J. Clin. Endocrinol. Metab. 89, 3896-3902.
7. Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L., Wegmann, D. R., Hutton, J. C., Elliott, J. F., Eisenbarth, G. S. (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435, 220-223.
8. Jasinski, J. M., Yu, L., Nakayama, M., Li, M. M., Lipes, M. A., Eisenbarth, G. S., Liu, E. (2006) Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout. Diabetes 55, 1978-1984.
9. Ott, P. A., Dittrich, M. T., Herzog, B. A., Guerkov, R., Gottlieb, P. A., Putnam, A. L., Durinovic-Bello, I., Boehm, B. O., Tary-Lehmann, M., Lehmann, P. V. (2004) T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J. Clin. Immunol. 24, 327-339.
10. Wagner Jr., D. H., Vaitaitis, G., Sanderson, R., Poulin, M., Dobbs, C., Haskins, K. (2002) Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc. Natl. Acad. Sci. USA 99, 3782-3787.
11. + auto-aggressive T cells during insulin-dependent diabetes mellitus. Eur. J. Immunol. 34, 1488-1497.
12. Vaitaitis, G. M., Poulin, M., Sanderson, R. J., Haskins, K. J., Wagner Jr., D. H. (2003) Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery. J. Immunol. 170, 3455-3459.
13. Wagner Jr., D. H., Newell, E., Sanderson, R., Freed, J. H., Newell, M. K. (1999) Increased expression of CD40 on thymocytes and peripheral T cells in autoimmunity: a mechanism for acquiring changes in the peripheral T cell receptor repertoire. Int. J. Mol. Med. 4, 231-242.
14. Balasa, B., Krahl, T., Patstone, G., Lee, J., Tisch, R., McDevitt, H. O., Sarvetnick, N. (1997) CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159, 4620-4627.
15. Yellin, M. J., Sinning, J., Covey, L. R., Sherman, W., Lee, J. J., Glickman-Nir, E., Sippel, K. C., Rogers, J., Cleary, A. M., Parker, M., Chess, L., Lederman, S. (1994) T lymphocytes T cell-B cell activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80(B7/BB1) and enhance their costimulatory activity. J. Immunol. 153, 666-674.
16. Stumpf, C., Lehner, C., Eskafi, S., Raaz, D., Yilmaz, A., Ropers, S., Schmeisser, A., Ludwig, J., Daniel, W. G., Garlichs, C. D. (2003) Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure. Eur. J. Heart Fail. 5, 629-637.
17. Cipollone, F., Chiarelli, F., Davi, G., Ferri, C., Desideri, G., Fazia, M., Iezzi, A., Santilli, F., Pini, B., Cuccurullo, C., Tumini, S., Del Ponte, A., Santucci, A., Cuccurullo, F., Mezzetti, A. (2005) Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia 48, 1216-1224.
18. Toubi, E., Shoenfeld, Y. (2004) The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37, 457-464.
19. Harding, S. A., Sommerfield, A. J., Sarma, J., Twomey, P. J., Newby, D. E., Frier, B. M., Fox, K. A. (2004) Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 176, 321-325.
20. Robinson, D. S. (2005) The role of regulatory T lymphocytes in asthma pathogenesis. Curr. Allergy Asthma Rep. 5, 136-141.
21. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., Rudensky, A. Y. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341.
22. Pop, S. M., Wong, C. P., Culton, D. A., Clarke, S. H., Tisch, R. (2005) Single cell analysis shows decreasing FoxP3 and TGF{β}1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J. Exp. Med. 201, 1333-1346.
23. McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., Byrne, M. C. (2002) CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid- induced TNF receptor. Immunity 16, 311-323.
24. Salomon, B., Lenschow, D., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., Bluestone, J. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440.
25. Bach, J. F., Chatenoud, L. (2001) Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19, 131-161.
26. Lepault, F., Gagnerault, M. C. (2000) Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164, 240-247.
27. Eggena, M. P., Walker, L. S., Nagabhushanam, V., Barron, L., Chodos, A., Abbas, A. K. (2004) Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen. J. Exp. Med. 199, 1725-1730.
28. Salomon, B., Bluestone, J. A. (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19, 225-252.
29. Stassen, M., Fondel, S., Bopp, T., Richter, C., Muller, C., Kubach, J., Becker, C., Knop, J., Enk, A. H., Schmitt, S., Schmitt, E., Jonuleit, H. (2004) Human CD25+ regulatory T cells: two subsets defined by the integrins α4β7 or α4β1 confer distinct suppressive properties upon CD4+ T helper cells. Eur. J. Immunol. 34, 1303-1311.
30. Every, A. L., Kramer, D. R., Mannering, S. I., Lew, A. M., Harrison, L. C. (2006) Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes. J. Immunol. 176, 4608-4615.
31. Liu, W., Putnam, A. L., Xu-Yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., Fazekas de St Groth, B., Clayberger, C., Soper, D. M., Ziegler, S. F., Bluestone, J. A. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701-1711.
32. Nishikawa, H., Kato, T., Tawara, I., Saito, K., Ikeda, H., Kuribayashi, K., Allen, P. M., Schreiber, R. D., Sakaguchi, S., Old, L. J., Shiku, H. (2005) Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells. J. Exp. Med. 201, 681-686.
33. Setoguchi, R., Hori, S., Takahashi, T., Sakaguchi, S. (2005) Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723-735.
34. Sakaguchi, S. (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352.
35. Nishimura, E., Sakihama, T., Setoguchi, R., Tanaka, K., Sakaguchi, S. (2004) Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+ CD4+ regulatory T cells. Int. Immunol. 16, 1189-1201.
36. Bluestone, J. A., Abbas, A. K. (2003) Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257.
37. Heath, A. W., Wu, W. W., Howard, M. C. (1994) Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 24, 1828-1834.
38. Wagner Jr., D. H., Hagman, J., Linsley, P. S., Hodsdon, W., Freed, J. H., Newell, M. K. (1996) Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2. J. Exp. Med. 184, 1631-1637.
39. Kim, S., Kim, K. A., Hwang, D. Y., Lee, T. H., Kayagaki, N., Yagita, H., Lee, M. S. (2000) Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved. J. Immunol. 164, 2931-2936.
40. Reparon-Schuijt, C. C., van Esch, W. J., van Kooten, C., Rozier, B. C., Levarht, E. W., Breedveld, F. C., Verweij, C. L. (2000) Regulation of synovial B cell survival in rheumatoid arthritis by vascular cell adhesion molecule 1 (CD106) expressed on fibroblast-like synoviocytes. Arthritis Rheum. 43, 1115-1121.
41. Quah, B. J., Warren, H. S., Parish, C. R. (2007) Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc. 2, 2049-2056.
42. Serreze, D. V. (1993) Autoimmune diabetes results from genetic defects manifest by antigen presenting cells. FASEB J. 7, 1092-1096.
43. Ott, P. A., Anderson, M. R., Tary-Lehmann, M., Lehmann, P. V. (2005) CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. Cell. Immunol. 235, 1-11.
44. Wagner Jr., D. H. (2007) Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad. Clin. Immunol. 123, 1-6.
45. Hoglund, P., Mintern, J., Waltzinger, C., Heath, W., Benoist, C., Mathis, D. (1999) Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189, 331-339.
46. Alard, P., Manirarora, J. N., Parnell, S. A., Hudkins, J. L., Clark, S. L., Kosiewicz, M. M. (2006) Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice. Diabetes 55, 2098-2105.
47. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z., Marshak-Rothstein, A. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
48. Maher, S., Toomey, D., Condron, C., Bouchier-Hayes, D. (2002) Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumor counterattack. Immunol. Cell Biol. 80, 131-137.
49. Desbarats, J., Wade, T., Wade, W. F., Newell, M. K. (1999) Dichotomy between naive and memory CD4(+) T cell responses to Fas engagement. Proc. Natl. Acad. Sci. USA 96, 8104-8109.
50. Moses, C. T., Thorstenson, K. M., Jameson, S. C., Khoruts, A. (2003) Competition for self ligands restrains homeostatic proliferation of naive CD4 T cells. Proc. Natl. Acad. Sci. USA 100, 1185-1190.
51. Lafaille, J. J. (1998) The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9, 139-151.
52. Elson, C. J., Barker, R. N. (2000) Helper T cells in antibody-mediated, organ-specific autoimmunity. Curr. Opin. Immunol. 12, 664-669.
53. Sabelko-Downes, K. A., Russell, J. H., Cross, A. H. (1999) Role of Fas-FasL interactions in the pathogenesis and regulation of autoimmune demyelinating disease. J. Neuroimmunol. 100, 42-52.
54. Mellanby, R. J., Thomas, D., Phillips, J. M., Cooke, A. (2007) Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology 121, 15-28.
55. Feuerer, M., Jiang, W., Holler, P. D., Satpathy, A., Campbell, C., Bogue, M., Mathis, D., Benoist, C. (2007) Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 104, 18181-18186.
56. Waid, D. M., Wagner, R. J., Putnam, A., Vaitaitis, G. M., Pennock, N. D., Calverley, D. C., Gottlieb, P., Wagner Jr., D. H. (2007) A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes. Clin. Immunol. 124, 138-148.
57. Matsui, K., Jodo, S., Xiao, S., Ju, S. T. (1999) Hypothesis: a recurrent, moderate activation fosters systemic autoimmunity - the apoptotic roles of TCR, IL-2 and Fas ligand. J. Biomed. Sci. 6, 306-313.